Pre-order Enquiry
Request Free Sample
Global Non-oncology Biopharmaceuticals Market Research Report 2024
SKU ID : QYR-27187346 | Publishing Date : 12-Apr-2024 | No. of pages : 107
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Non-oncology Biopharmaceuticals Market Research Report 2024
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biologics
1.2.3 Biosimilars
1.3 Market by Application
1.3.1 Global Non-oncology Biopharmaceuticals Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Immunology
1.3.3 Endocrinology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-oncology Biopharmaceuticals Market Perspective (2019-2030)
2.2 Non-oncology Biopharmaceuticals Growth Trends by Region
2.2.1 Global Non-oncology Biopharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Non-oncology Biopharmaceuticals Historic Market Size by Region (2019-2024)
2.2.3 Non-oncology Biopharmaceuticals Forecasted Market Size by Region (2025-2030)
2.3 Non-oncology Biopharmaceuticals Market Dynamics
2.3.1 Non-oncology Biopharmaceuticals Industry Trends
2.3.2 Non-oncology Biopharmaceuticals Market Drivers
2.3.3 Non-oncology Biopharmaceuticals Market Challenges
2.3.4 Non-oncology Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-oncology Biopharmaceuticals Players by Revenue
3.1.1 Global Top Non-oncology Biopharmaceuticals Players by Revenue (2019-2024)
3.1.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Players (2019-2024)
3.2 Global Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-oncology Biopharmaceuticals Revenue
3.4 Global Non-oncology Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Non-oncology Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-oncology Biopharmaceuticals Revenue in 2023
3.5 Non-oncology Biopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Non-oncology Biopharmaceuticals Product Solution and Service
3.7 Date of Enter into Non-oncology Biopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-oncology Biopharmaceuticals Breakdown Data by Type
4.1 Global Non-oncology Biopharmaceuticals Historic Market Size by Type (2019-2024)
4.2 Global Non-oncology Biopharmaceuticals Forecasted Market Size by Type (2025-2030)
5 Non-oncology Biopharmaceuticals Breakdown Data by Application
5.1 Global Non-oncology Biopharmaceuticals Historic Market Size by Application (2019-2024)
5.2 Global Non-oncology Biopharmaceuticals Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Non-oncology Biopharmaceuticals Market Size (2019-2030)
6.2 North America Non-oncology Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Non-oncology Biopharmaceuticals Market Size by Country (2019-2024)
6.4 North America Non-oncology Biopharmaceuticals Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-oncology Biopharmaceuticals Market Size (2019-2030)
7.2 Europe Non-oncology Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Non-oncology Biopharmaceuticals Market Size by Country (2019-2024)
7.4 Europe Non-oncology Biopharmaceuticals Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-oncology Biopharmaceuticals Market Size (2019-2030)
8.2 Asia-Pacific Non-oncology Biopharmaceuticals Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region (2019-2024)
8.4 Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-oncology Biopharmaceuticals Market Size (2019-2030)
9.2 Latin America Non-oncology Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Non-oncology Biopharmaceuticals Market Size by Country (2019-2024)
9.4 Latin America Non-oncology Biopharmaceuticals Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-oncology Biopharmaceuticals Market Size (2019-2030)
10.2 Middle East & Africa Non-oncology Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country (2019-2024)
10.4 Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Non-oncology Biopharmaceuticals Introduction
11.1.4 Roche Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Non-oncology Biopharmaceuticals Introduction
11.2.4 Sanofi Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Introduction
11.3.4 Johnson & Johnson Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Non-oncology Biopharmaceuticals Introduction
11.4.4 Pfizer Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Detail
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Introduction
11.5.4 Novo Nordisk Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.5.5 Novo Nordisk Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Non-oncology Biopharmaceuticals Introduction
11.6.4 Novartis Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Non-oncology Biopharmaceuticals Introduction
11.7.4 Merck Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Teva
11.8.1 Teva Company Detail
11.8.2 Teva Business Overview
11.8.3 Teva Non-oncology Biopharmaceuticals Introduction
11.8.4 Teva Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.8.5 Teva Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Non-oncology Biopharmaceuticals Introduction
11.9.4 Eli Lilly Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.9.5 Eli Lilly Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Detail
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Introduction
11.10.4 Bristol-Myers Squibb Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Introduction
11.11.4 GlaxoSmithKline Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.11.5 GlaxoSmithKline Recent Development
11.12 UCB Pharma
11.12.1 UCB Pharma Company Detail
11.12.2 UCB Pharma Business Overview
11.12.3 UCB Pharma Non-oncology Biopharmaceuticals Introduction
11.12.4 UCB Pharma Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.12.5 UCB Pharma Recent Development
11.13 Amgen
11.13.1 Amgen Company Detail
11.13.2 Amgen Business Overview
11.13.3 Amgen Non-oncology Biopharmaceuticals Introduction
11.13.4 Amgen Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.13.5 Amgen Recent Development
11.14 AbbVie
11.14.1 AbbVie Company Detail
11.14.2 AbbVie Business Overview
11.14.3 AbbVie Non-oncology Biopharmaceuticals Introduction
11.14.4 AbbVie Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.14.5 AbbVie Recent Development
11.15 Takeda
11.15.1 Takeda Company Detail
11.15.2 Takeda Business Overview
11.15.3 Takeda Non-oncology Biopharmaceuticals Introduction
11.15.4 Takeda Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.15.5 Takeda Recent Development
11.16 AstraZeneca
11.16.1 AstraZeneca Company Detail
11.16.2 AstraZeneca Business Overview
11.16.3 AstraZeneca Non-oncology Biopharmaceuticals Introduction
11.16.4 AstraZeneca Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.16.5 AstraZeneca Recent Development
11.17 Mylan
11.17.1 Mylan Company Detail
11.17.2 Mylan Business Overview
11.17.3 Mylan Non-oncology Biopharmaceuticals Introduction
11.17.4 Mylan Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.17.5 Mylan Recent Development
11.18 LEO Pharma
11.18.1 LEO Pharma Company Detail
11.18.2 LEO Pharma Business Overview
11.18.3 LEO Pharma Non-oncology Biopharmaceuticals Introduction
11.18.4 LEO Pharma Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.18.5 LEO Pharma Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Detail
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Introduction
11.19.4 Boehringer Ingelheim Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.19.5 Boehringer Ingelheim Recent Development
11.20 Alexion Pharmaceuticals
11.20.1 Alexion Pharmaceuticals Company Detail
11.20.2 Alexion Pharmaceuticals Business Overview
11.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Introduction
11.20.4 Alexion Pharmaceuticals Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.20.5 Alexion Pharmaceuticals Recent Development
11.21 Elusys Therapeutics
11.21.1 Elusys Therapeutics Company Detail
11.21.2 Elusys Therapeutics Business Overview
11.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Introduction
11.21.4 Elusys Therapeutics Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.21.5 Elusys Therapeutics Recent Development
11.22 Swedish Orphan Biovitrum
11.22.1 Swedish Orphan Biovitrum Company Detail
11.22.2 Swedish Orphan Biovitrum Business Overview
11.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Introduction
11.22.4 Swedish Orphan Biovitrum Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.22.5 Swedish Orphan Biovitrum Recent Development
11.23 Biogen
11.23.1 Biogen Company Detail
11.23.2 Biogen Business Overview
11.23.3 Biogen Non-oncology Biopharmaceuticals Introduction
11.23.4 Biogen Revenue in Non-oncology Biopharmaceuticals Business (2019-2024)
11.23.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Non-oncology Biopharmaceuticals Market Research Report 2024
List of TablesTable 1. Global Non-oncology Biopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Biologics
Table 3. Key Players of Biosimilars
Table 4. Global Non-oncology Biopharmaceuticals Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Non-oncology Biopharmaceuticals Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Non-oncology Biopharmaceuticals Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Non-oncology Biopharmaceuticals Market Share by Region (2019-2024)
Table 8. Global Non-oncology Biopharmaceuticals Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Non-oncology Biopharmaceuticals Market Share by Region (2025-2030)
Table 10. Non-oncology Biopharmaceuticals Market Trends
Table 11. Non-oncology Biopharmaceuticals Market Drivers
Table 12. Non-oncology Biopharmaceuticals Market Challenges
Table 13. Non-oncology Biopharmaceuticals Market Restraints
Table 14. Global Non-oncology Biopharmaceuticals Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Non-oncology Biopharmaceuticals Market Share by Players (2019-2024)
Table 16. Global Top Non-oncology Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-oncology Biopharmaceuticals as of 2023)
Table 17. Ranking of Global Top Non-oncology Biopharmaceuticals Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Non-oncology Biopharmaceuticals Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-oncology Biopharmaceuticals Product Solution and Service
Table 21. Date of Enter into Non-oncology Biopharmaceuticals Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-oncology Biopharmaceuticals Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Non-oncology Biopharmaceuticals Revenue Market Share by Type (2019-2024)
Table 25. Global Non-oncology Biopharmaceuticals Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Non-oncology Biopharmaceuticals Revenue Market Share by Type (2025-2030)
Table 27. Global Non-oncology Biopharmaceuticals Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Non-oncology Biopharmaceuticals Revenue Market Share by Application (2019-2024)
Table 29. Global Non-oncology Biopharmaceuticals Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Non-oncology Biopharmaceuticals Revenue Market Share by Application (2025-2030)
Table 31. North America Non-oncology Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Non-oncology Biopharmaceuticals Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Non-oncology Biopharmaceuticals Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Non-oncology Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Non-oncology Biopharmaceuticals Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Non-oncology Biopharmaceuticals Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Non-oncology Biopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Non-oncology Biopharmaceuticals Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Non-oncology Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Non-oncology Biopharmaceuticals Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Non-oncology Biopharmaceuticals Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Non-oncology Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Non-oncology Biopharmaceuticals Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Non-oncology Biopharmaceuticals Product
Table 49. Roche Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Non-oncology Biopharmaceuticals Product
Table 54. Sanofi Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Non-oncology Biopharmaceuticals Product
Table 59. Johnson & Johnson Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Non-oncology Biopharmaceuticals Product
Table 64. Pfizer Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novo Nordisk Company Detail
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Non-oncology Biopharmaceuticals Product
Table 69. Novo Nordisk Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 70. Novo Nordisk Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Non-oncology Biopharmaceuticals Product
Table 74. Novartis Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Merck Company Detail
Table 77. Merck Business Overview
Table 78. Merck Non-oncology Biopharmaceuticals Product
Table 79. Merck Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Teva Company Detail
Table 82. Teva Business Overview
Table 83. Teva Non-oncology Biopharmaceuticals Product
Table 84. Teva Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 85. Teva Recent Development
Table 86. Eli Lilly Company Detail
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Non-oncology Biopharmaceuticals Product
Table 89. Eli Lilly Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. Bristol-Myers Squibb Company Detail
Table 92. Bristol-Myers Squibb Business Overview
Table 93. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product
Table 94. Bristol-Myers Squibb Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 95. Bristol-Myers Squibb Recent Development
Table 96. GlaxoSmithKline Company Detail
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline Non-oncology Biopharmaceuticals Product
Table 99. GlaxoSmithKline Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. UCB Pharma Company Detail
Table 102. UCB Pharma Business Overview
Table 103. UCB Pharma Non-oncology Biopharmaceuticals Product
Table 104. UCB Pharma Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 105. UCB Pharma Recent Development
Table 106. Amgen Company Detail
Table 107. Amgen Business Overview
Table 108. Amgen Non-oncology Biopharmaceuticals Product
Table 109. Amgen Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 110. Amgen Recent Development
Table 111. AbbVie Company Detail
Table 112. AbbVie Business Overview
Table 113. AbbVie Non-oncology Biopharmaceuticals Product
Table 114. AbbVie Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 115. AbbVie Recent Development
Table 116. Takeda Company Detail
Table 117. Takeda Business Overview
Table 118. Takeda Non-oncology Biopharmaceuticals Product
Table 119. Takeda Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 120. Takeda Recent Development
Table 121. AstraZeneca Company Detail
Table 122. AstraZeneca Business Overview
Table 123. AstraZeneca Non-oncology Biopharmaceuticals Product
Table 124. AstraZeneca Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 125. AstraZeneca Recent Development
Table 126. Mylan Company Detail
Table 127. Mylan Business Overview
Table 128. Mylan Non-oncology Biopharmaceuticals Product
Table 129. Mylan Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 130. Mylan Recent Development
Table 131. LEO Pharma Company Detail
Table 132. LEO Pharma Business Overview
Table 133. LEO Pharma Non-oncology Biopharmaceuticals Product
Table 134. LEO Pharma Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 135. LEO Pharma Recent Development
Table 136. Boehringer Ingelheim Company Detail
Table 137. Boehringer Ingelheim Business Overview
Table 138. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product
Table 139. Boehringer Ingelheim Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 140. Boehringer Ingelheim Recent Development
Table 141. Alexion Pharmaceuticals Company Detail
Table 142. Alexion Pharmaceuticals Business Overview
Table 143. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product
Table 144. Alexion Pharmaceuticals Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 145. Alexion Pharmaceuticals Recent Development
Table 146. Elusys Therapeutics Company Detail
Table 147. Elusys Therapeutics Business Overview
Table 148. Elusys Therapeutics Non-oncology Biopharmaceuticals Product
Table 149. Elusys Therapeutics Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 150. Elusys Therapeutics Recent Development
Table 151. Swedish Orphan Biovitrum Company Detail
Table 152. Swedish Orphan Biovitrum Business Overview
Table 153. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product
Table 154. Swedish Orphan Biovitrum Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 155. Swedish Orphan Biovitrum Recent Development
Table 156. Biogen Company Detail
Table 157. Biogen Business Overview
Table 158. Biogen Non-oncology Biopharmaceuticals Product
Table 159. Biogen Revenue in Non-oncology Biopharmaceuticals Business (2019-2024) & (US$ Million)
Table 160. Biogen Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-oncology Biopharmaceuticals Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Non-oncology Biopharmaceuticals Market Share by Type: 2023 VS 2030
Figure 3. Biologics Features
Figure 4. Biosimilars Features
Figure 5. Global Non-oncology Biopharmaceuticals Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Non-oncology Biopharmaceuticals Market Share by Application: 2023 VS 2030
Figure 7. Immunology Case Studies
Figure 8. Endocrinology Case Studies
Figure 9. Others Case Studies
Figure 10. Non-oncology Biopharmaceuticals Report Years Considered
Figure 11. Global Non-oncology Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Non-oncology Biopharmaceuticals Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Non-oncology Biopharmaceuticals Market Share by Region: 2023 VS 2030
Figure 14. Global Non-oncology Biopharmaceuticals Market Share by Players in 2023
Figure 15. Global Top Non-oncology Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-oncology Biopharmaceuticals as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Non-oncology Biopharmaceuticals Revenue in 2023
Figure 17. North America Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Non-oncology Biopharmaceuticals Market Share by Country (2019-2030)
Figure 19. United States Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Non-oncology Biopharmaceuticals Market Share by Country (2019-2030)
Figure 23. Germany Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Non-oncology Biopharmaceuticals Market Share by Region (2019-2030)
Figure 31. China Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Non-oncology Biopharmaceuticals Market Share by Country (2019-2030)
Figure 39. Mexico Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Non-oncology Biopharmaceuticals Market Share by Country (2019-2030)
Figure 43. Turkey Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Non-oncology Biopharmaceuticals Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Roche Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 46. Sanofi Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 47. Johnson & Johnson Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 49. Novo Nordisk Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 52. Teva Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 53. Eli Lilly Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 56. UCB Pharma Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 57. Amgen Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 58. AbbVie Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 59. Takeda Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 60. AstraZeneca Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 61. Mylan Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 62. LEO Pharma Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 64. Alexion Pharmaceuticals Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 65. Elusys Therapeutics Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 66. Swedish Orphan Biovitrum Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 67. Biogen Revenue Growth Rate in Non-oncology Biopharmaceuticals Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
